Yuan Liji and Huicun Medical have reached a deep strategic cooperation to promote the high-quality development of biological sample storage
On February 22, 2024, Heyuan Biotechnology's subsidiary Heyuan Liji (Shanghai) Biotechnology Co., Ltd. (hereinafter referred to as "Heyuan Liji") announced a deep strategic cooperation with Shanghai Huicun Medical Technology Co., Ltd. (hereinafter referred to as "Huicun Medical"). The two parties have reached a high degree of agreement on product development and market expansion in the fields of organization, cell preservation, and transportation, with the aim of accelerating product innovation in the field of biological sample storage and transportation, and promoting high-quality development in the fields of cell and gene therapy.
（Both parties attended the signing ceremony on the same day）
Both parties have reached a deep strategic cooperation agreement
Wang Fujie, Vice General Manager of Heyuan Biotechnology, stated that the strategic cooperation between Heyuan Liji and Huicun Medical is an important sign of Heyuan Liji's good start in 2024. In the future, both parties will expand broader cooperation space, further upgrade products and services, lead the innovation pace of biological sample storage and transportation products, and contribute more strength to the field of cell and gene therapy。”
Yan Hexin, General Manager of Huicun Medical, said, "Heyuan Liji is a holding subsidiary of Heyuan Biotechnology (stock code: 688238), focusing on product research and development, production, and sales in the field of life sciences. We are very pleased to have reached a strategic cooperation with Heyuan Liji. Huicun Medical has years of technical accumulation in the fields of biological sample cryopreservation and live tissue transportation. Multiple products such as cell cryopreservation solution and tissue transportation protection solution have reached or exceeded similar imported products. The two sides are highly compatible in the industry chain and have broad cooperation space. This cooperation will accelerate the integration of both parties' capabilities and provide better products for our customers
Huicun Medical is a well-known multi-functional innovative enterprise that integrates production, research and development, and sales. It has mature technology for cell and tissue transportation and preservation. As an important product branch of Heyuan Liji, we are pleased to deepen cooperation between the two parties. In the future, we will fully utilize the advantages of both parties' technology platforms and products, work together to fully empower the development of the life science industry, and accelerate the replacement of domestic reagents in the field of cell and tissue transportation and preservation
About He Yuan Biology
Founded in 2013, Heyuan Biotechnology (stock code: 688238) is a biotechnology company focused on the field of gene therapy, specializing in providing CRO services such as gene therapy vector development and gene function research for basic research in gene therapy; Provide CDMO services for the research and development of gene therapy drugs, including recombinant viral vector drugs, oncolytic viruses, CAR-T cell therapy products, etc., including process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production. With the mission of "empowering gene therapy and safeguarding life and health together" and the core of gene therapy carrier research and production, the company will adhere to customer centricity and provide professional services as its own responsibility, build an internationally leading gene and cell therapy CXO group enterprise, accelerate the basic research, drug discovery, pharmaceutical research, clinical and commercialization process of gene therapy, promote the development of the gene therapy industry, and benefit human health!
About He Yuan Li Ji
Heyuan Liji (Shanghai) Biotechnology Co., Ltd. was established in 2023 by Heyuan Biotechnology (stock code: 688238) as a domestic biological reagent company that integrates research and development, production, and sales. It focuses on the fields of life sciences and biotechnology, and is committed to providing customers with advanced technology, convenient and easy-to-use, and cost-effective reagent products. The product range includes experimental reagents and reagent kits related to cell biology, molecular biology, immunology, and biochemistry.
Currently, authorized agents are available in over 40 cities across the country; Directly serving thousands of end customers, including CROs, pharmaceutical companies, universities, hospitals, and research institutes; Li Ji's products have helped clients publish hundreds of SCI papers and multiple CNS papers.
About Huicun Medical
Shanghai Huicun Medical Technology Co., Ltd. was established in Zhangjiang Science City. It is an innovative cell drug research and development enterprise rooted in the field of regenerative medicine, focusing on providing new cell therapy solutions for patients with moderate to severe liver disease. It has taken the lead in establishing an independent and original small molecule reprogramming system internationally, solving the scientific difficulties and technical bottlenecks of maintaining the function of human liver cells in vitro and large-scale cultivation. It provides a key source of liver cells for liver cell transplantation and clinical applications of bioaArtificial Liver. The company takes "awakening regeneration and bidding farewell to transplantation" as its corporate mission, and is committed to making unremitting efforts to completely solve the problem of liver disease for humanity.
Based on research and development needs, the company has multiple self-developed patented technologies in the storage and transportation of cell and tissue samples, with some products reaching or exceeding similar imported products.
Back
